APA (7th ed.) Citation

Dösch, A., Repp, J., Hofmann, N., Erbel, C., Frankenstein, L., Gleißner, C. A., . . . Katus, H. (2012). Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients. Drug design, development and therapy, 6, . https://doi.org/10.2147/DDDT.S36578

Chicago Style (17th ed.) Citation

Dösch, Andreas, et al. "Effects of Oral Valganciclovir Prophylaxis for Cytomegalovirus Infection in Heart Transplant Patients." Drug Design, Development and Therapy 6 (2012). https://doi.org/10.2147/DDDT.S36578.

MLA (9th ed.) Citation

Dösch, Andreas, et al. "Effects of Oral Valganciclovir Prophylaxis for Cytomegalovirus Infection in Heart Transplant Patients." Drug Design, Development and Therapy, vol. 6, 2012, https://doi.org/10.2147/DDDT.S36578.